Naslov
Urolithiasis and Osteoporosis: Clinical Relevance and Therapeutic Implications

Autori
Bilić-Čurčić, Ines ; Milas-Ahić, Jasminka ; Smolić, Martina ; Smolić, Robert ; Mihaljević, Ivan ; Tucak Zorić, Sandra ; Omanović, Tea ; Kuna, Lucija ; Jakab, Jelena

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Knjiga sažetaka: 12. osječki urološki dani, 5. osječki nefrološki dani, 4. sekcija medicinskih sestara i tehničara urologije i nefrologije / - Osijek, 2017, 30-30

Skup
12. osječki urološki dani/ 5. osječki nefrološki dani

Mjesto i datum
Osijek, Hrvatska, 11.05.2017. - 13.05.2017

Vrsta sudjelovanja
Poster

Vrsta recenzije
Domaća recenzija

Ključne riječi
osteporosis ; urolithiasis ; bone loss ; prevention ; treatment

Sažetak
Several clinical and epidemiological studies revealed increased bone turnover and lower bone mass in patients with urolithiasis. Bone mass loss is particularly evident in idiopathic calcium stone formers. However, pathogenetic mechanisms and factors implicated in bone loss in these patients are still unknown. Dietary calcium restriction, increased intake of salt and animal proteins, vitamin D receptor polymorphisms are likely risk factors, while role of inflammatory cytokines, osteopontin and prostaglandin mediated bone resorption is yet to be determined. Regarding treatment and prevention, it has been proven that calcium supplements and high calcium diet with the addition of potassium alkali have an important role in prevention and treatment of both, urolithiasis and osteoporosis. Thiazide diuretics reduce hypercalciuria in renal tubules, and in addition promote osteoblast differentiation. Finally, bisphosphonates, a commonly used drugs in treatement of osteoporosis, show the potential to inhibit calcium stone formation, whereas a possible protective effect of antioxidants in bone loss and renal injurie needs to be investigated further.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti

POVEZANOST RADA